KEPPRA

Generic: LEVETIRACETAM

UCBManufacturer
INTRAVENOUSRoute
LEVETIRACETAMActive Substance
2006-07-31Original Approval

KEPPRA is FDA application NDA021872, sponsored by UCB INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
SEIZURE
16,227 reports
2
DRUG INEFFECTIVE
12,556 reports
3
OFF LABEL USE
9,747 reports
4
FATIGUE
5,664 reports
5
SOMNOLENCE
4,247 reports
6
EPILEPSY
4,201 reports
7
CONVULSION
4,079 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
3,821 reports
9
FALL
3,812 reports
10
HEADACHE
3,770 reports